PMS20 COST EFFECTIVENESS ANALYSIS OF MANAGING CHRONIC GOUT WITH FEBUOXSTAT (ULORIC) VERSUS ALLOPURINOL (ZYLOPRIM)
May 1, 2010, 00:00
10.1016/S1098-3015(10)72608-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)72608-5/fulltext
Title :
PMS20 COST EFFECTIVENESS ANALYSIS OF MANAGING CHRONIC GOUT WITH FEBUOXSTAT (ULORIC) VERSUS ALLOPURINOL (ZYLOPRIM)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72608-5&doi=10.1016/S1098-3015(10)72608-5
First page :
Section Title :
Open access? :
No
Section Order :
153